Leadership Team
Terry Novak
Chief Executive Officer
Terry brings a diverse background in the pharmaceutical, biotech, and CDMO industries with extensive executive leadership experience in business development, manufacturing, and commercial operations. Over the past 23 years, he has developed a solid reputation in the API, oral solid dose, and sterile fill-finish sectors for successfully executing strategic operational and business development plans and building highly functioning customer-focused teams. Terry’s CDMO experience includes service as COO of Bright Path Labs, CEO of Tedor Pharmaceuticals, President of Patheon North America, and President of DSM Pharmaceutical Products. After graduating from Muhlenberg College, Terry started his career in sales at Bristol-Myers Squibb.
Matt Delaney
Chief Business Development Officer
With over two decades of extensive leadership in business development and marketing, Matt Delaney is known for his passion and ability to implement effective sales and marketing strategies while cultivating high-performance teams. He has held key roles such as Vice President of Business Development for Exela’s CDMO business unit, Vice President of Business Development & Marketing for Cytovance Biologics, and executive-level positions at Lake Pharma and Nitto Avecia Pharma Services. Matt also served as Global Vice President of Business Development at Pharm-Olam International and President of Datatrak International, and spent twelve years as the Senior Director of Consulting Services for Dell Technologies in the Life Sciences & Healthcare business units. He holds an undergraduate degree from San Diego State University, an MBA from the University of La Verne, and a master’s level certification in International Business from Western International University in Arizona.
Eric Kizior
Vice President Commercial Business
Eric is an accomplished leader in the healthcare industry, with a distinguished 25-year tenure in commercial pharmaceuticals. His diverse expertise spans various therapeutic areas, underscored by multiple significant product launches. As a Bradley University graduate, Mr. Kizior’s solid educational foundation in finance enriches his innovative strategies in commercial development. His approach, combining deep financial insight with a broad understanding of healthcare, aligns seamlessly with Benuvia’s vision of pioneering and patient-focused pharmaceutical solutions.
Mohammed Kabir
R&D Pharmaceutical Formulation Development Management
Mohammed is an accomplished professional with over 32 years of experience in pharmaceutical formulation and process development. His expertise spans a wide range of dosage forms, including injectables, ophthalmics, and inhalation products, for both human and veterinary applications. Before Benuvia, he contributed significantly to Apotex Inc. and Akorn Pharmaceuticals and shared his knowledge by teaching at Seneca College. Holding a Bachelor’s and Master of Pharmacy, Mohammed’s experience with bio-equivalence and product development enriches Benuvia’s commitment to innovative and effective pharmaceutical solutions.
Monica Gorbet
Senior Director, Head of Quality
Leading the Quality department at Benuvia, Monica is a testament to excellence with her 26 years in the Biopharmaceutical and Pharmaceutical Industry. Her journey spans small to large companies and CDMO roles, where she honed her expertise in Quality Systems Development and Management. Monica’s extensive background covers a spectrum from drug substance to drug product manufacturing, inclusive of various forms including solid, liquid, and combination products. Her academic background in Biology and Chemistry from Texas A&M-Kingsville further enriches her ability to oversee quality from clinical development to commercial products, aligning with Benuvia’s dedication to high standards.
R. Scott Warlick
Vice President of Manufacturing
As Benuvia’s Vice President of Manufacturing since 2020, Scott exemplifies a career steeped in pharmaceutical excellence. His 30-year journey, marked by pivotal roles at Mallinckrodt, Mylan, and Insys, underscores his mastery in operations management. Scott’s application of six sigma and lean manufacturing principles in pharmaceutical production, along with his proficiency in small molecule API and oral solid dose unit operations, mirrors Benuvia’s dedication to cutting-edge and efficient manufacturing techniques. His educational background, with a BS in Chemical Engineering from North Carolina State University and an MBA from Duke University’s executive program, fortifies his strategic leadership, aligning with Benuvia’s vision of setting new benchmarks in pharmaceutical manufacturing.
Wish
to learn more?
Wish to learn more?
Take the next step towards unlocking your product's potential.
Let's embark on a journey of innovation and success together.
